Your provider will review potential risks during your consultation
Pharmaceuticals and their metabolites can also show phytotoxic properties, e.g., -blockers and their metabolites inhibit the photosynthesis rate in green algae (Escher et al
By keeping the structure so close to the native hormone, the researchers aimed to create a compound that would preferentially bind to the primary target, the MC1R, with minimal spillover to other receptors
Monitoring and Follow-Up Establish a structured monitoring schedule: Monthly visits during dose titration and the first 6 months Quarterly visits once stable, assessing weight, tolerability, and metabolic parameters Annual comprehensive evaluation including lipid panel, HbA1c (if diabetic), liver function tests, and cardiovascular risk assessment Regular monitoring allows early identification of plateaus, adverse effects, or emerging medical issues that may require intervention